State Street® SPDR® S&P® Biotech ETF XBI

Medalist Rating as of | See State Street Investment Hub

Morningstar’s Analysis XBI

Will XBI outperform in the future?

Get our overall rating based on a fundamental assessment of the pillars below.

null Morningstar Automated Analysis

Morningstar Automated Analysis

Summary

State Street® SPDR® S&P® Biotech ETF holds a quantitatively derived Bronze Morningstar Medalist Rating. The rating reflects that it has scored better than the norm on factors Morningstar research associates with future outperformance relative to category peers.

Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings XBI

  • Current Portfolio Date
  • Equity Holdings —
  • Bond Holdings —
  • Other Holdings —
  • % Assets in Top 10 Holdings 16.9
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

Twist Bioscience Corp

2.20 221M
Healthcare

Moderna Inc

2.04 206M
Healthcare

Natera Inc

1.81 183M
Healthcare

United Therapeutics Corp

1.65 167M
Healthcare

Iovance Biotherapeutics Inc

1.59 160M
Healthcare

Biogen Inc

1.55 156M
Healthcare

Amgen Inc

1.53 154M
Healthcare

AbbVie Inc

1.52 153M
Healthcare

Spyre Therapeutics Inc

1.52 153M
Healthcare

CRISPR Therapeutics AG

1.49 151M
Healthcare

Sponsor Center